DVA

DaVita Inc.

Price

$149.49

return (12m)

p/e

20.27

p/bv

15.11

DIVIDEND YIELD

0.00%

DVA price

DaVita

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment DVA

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals DVA

Valuation

P/E

20.27

Sector -2.34

Industry 11.10

P/BV

15.11

Sector 2.17

Industry 3.33

P/Revenue (PSR)

1.15

Sector 2.00

Industry 1.71

EV/EBITDA

38.68

Sector -23.69

Industry -398.52

EV/EBIT

52.82

Sector -36.60

Industry -80.73

P/EBITDA

5.85

Sector -0.10

Industry 8.30

P/EBIT

7.95

Sector -2.08

Industry 5.69

P/Total Assets

0.91

Sector 1.18

Industry 1.57

P/Net Current Assets

-1.28

Sector -10.91

Industry -3.38

P/Working Capital

13.25

Sector 0.09

Industry 10.51

EPS

11.66

Sector -0.93

Industry 1.10

BVPS

15.64

Sector 3.87

Industry 14.82

Efficiency

Gross Margin

32.45%

Sector 44.28%

Industry 29.23%

EBITDA Margin

19.45%

Sector -291.45%

Industry 4.29%

EBIT Margin

14.24%

Sector -195.44%

Industry 1.44%

Operating Margin

14.82%

Sector -25.72%

Industry 2.16%

Net Profit Margins

5.65%

Sector -30.19%

Industry 2.77%

Asset Turnover

0.20

Sector 0.12

Industry 0.27

Profitability

ROE

74.55%

Sector -34.71%

Industry 6.97%

ROA

4.47%

Sector -28.76%

Industry 2.97%

ROIC

9.65%

Sector -441.27%

Industry -5.31%

Dividends

Dividend yield

0.00%

Sector -

Industry 0.01%

Payout

0.00%

Sector -

Industry 0.54%

Debt

Current Ratio

1.42

Sector 1.87

Industry 1.51

Net Debt / EBITDA

14.83

Sector -2.18

Industry -1.68

Net Debt / EBIT

20.25

Sector -0.74

Industry -7.00

Net Debt / Equity

9.39

Sector -0.34

Industry 0.05

Gross Debt / Equity

10.03

Sector -0.64

Industry 0.35

Equity/Assets

0.06

Sector 0.43

Industry 0.46

Liabilities/Assets

0.94

Sector 0.46

Industry 0.52

Growth

5Y Revenue CAGR

3.55%

Sector -

Industry -

5Y Earnings CAGR

-4.40%

Sector -

Industry -

FAIR VALUE OF DaVita ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$149.49

Fair Value

$64.06

Upside Return potential.

-57.15%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals DVA

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
DVA DaVita Inc.	$149.49	-3.87%	0.00%	20.27	15.11	74.55%	5.65%
EW Edwards Lifesciences Corp.	$78.21	12.69%	0.00%	45.55	4.82	10.58%	17.34%
BSX Boston Scientific Corp.	$63.80	-31.89%	0.00%	18.45	2.54	13.78%	17.29%
ABT Abbott Laboratories	$101.06	-18.35%	0.00%	25.64	3.09	12.06%	13.91%
ABMD Abiomed Inc.	$0.00	-	0.00%	64.27	11.14	17.32%	24.84%
ALGN Align Technology Inc.	$184.69	12.52%	0.00%	27.86	2.89	10.36%	10.50%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

DVA Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT DaVita

DaVita Inc.

Average Investor10 user rating

4.0 (0 people)

States of America

32 years

Founded: 1994

1995

Time since IPO - 31 years

69.000

Employees

DaVita Inc. (States of America) is listed on the NYSE and has a market capitalization of $15.84 billion, with shareholders equity totaling $1.05 billion.

The company employs approximately 69.000 people and operates in the Saúde sector, within the Serviços e Fornecedores de Saúde industry.

Over the past 12 months, DaVita Inc. reported $13.84 billion in revenue, generating net income of $781.42 million.

Key financial metrics include a P/E ratio of 20.27, a price-to-book (P/B) ratio of 15.11, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker DVA.

Market cap

$15.84 billion

Net worth

$1.05 billion

$1,048,170,000.00

Assets

$17.50 billion

$17,499,370,000.00

Total Shares Outstanding

67.00 million

67,000,000

Average Daily Trading Volume

$899.56 Thousand

$899,560.00

Sector

Saúde

Industry

Serviços e Fornecedores de Saúde

DVA

revenue by Business Segment DaVita

DVA revenue and profits

Financial Results DVA

DRAG THE FRAME TO SEE MORE DATA

DVA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$77.63 34,88% (12M)

P/E

46.88

2.46%

ROE

3.78%

P/BV

1.77

CI - Cigna

$272.65 --5,23% (12M)

P/E

11.58

2.16%

ROE

15.39%

P/BV

1.78

CNC - Centene

$37.26 38,72% (12M)

P/E

-4.98

0.00%

ROE

-29.93%

P/BV

1.49

HUM - Humana

$196.30 --14,19% (12M)

P/E

42.07

0.89%

ROE

6.06%

P/BV

2.55

SNY - Sanofi

$47.64 --3,72% (12M)

P/E

7.21

4.00%

ROE

17.79%

P/BV

1.28

LLY - Eli Lilly

$923.03 21,62% (12M)

P/E

41.74

0.55%

ROE

81.02%

P/BV

33.82

HCA - HCA Healthcare

$498.78 47,18% (12M)

P/E

12.41

0.80%

ROE

-228.14%

P/BV

-28.31

NVS - Novartis

$153.41 34,63% (12M)

P/E

21.74

2.01%

ROE

34.77%

P/BV

7.56